Results 1 to 10 of about 1,315,640 (306)

The Ethics and Economics of Pharmaceutical Pricing

Annual Review of Pharmacology and Toxicology, 2015
The cost of drugs is a major and rapidly rising component of health-care expenditures. We survey recent literature on the ethics and economics of skyrocketing pharmaceutical prices and find that advances in economic research have increased the sharpness and focus of the ethically based calls to increase access by modifying patent protection and ...
Sara, Parker-Lue, Michael, Santoro, Greg, Koski   +2 more
openaire   +3 more sources

Digital transformation, green finance, and pharmaceutical affordability in China: a health economics perspective [PDF]

Frontiers in Public Health
IntroductionDrug accessibility is a core challenge facing global public health systems, with financing costs directly affecting drug prices through cost-plus pricing mechanisms.
Jingdong Huang, Xinyi Zhang
doaj   +2 more sources

An economic evaluation of phacoemulsification and extracapsular cataract extraction in cataract surgery [PDF]

Vojnosanitetski Pregled, 2023
Background/Aim. Cataract surgery is one of the most often performed surgical interventions. The predominant method in Western countries is phacoemulsification, while in developing countries, the extracapsular cataract extraction (ECCE) method remains ...
Radujević Katarina, Bogavac-Stanojević Nataša, Nedeljković Rade, Lakić Dragana   +3 more
doaj   +1 more source

The economics of nature's healing touch: A systematic review and conceptual framework of green space, pharmaceutical prescriptions, and healthcare expenditure associations.

Science of the Total Environment, 2023
Green spaces play a crucial role in promoting sustainable and healthy lives. Recent evidence shows that green space also may reduce the need for healthcare, prescription medications, and associated costs.
M. Patwary, M. Bardhan, M. H. Browning, T. Astell-Burt, M. van den Bosch, Jiaying Dong, A. Dzhambov, P. Dadvand, T. Fasolino, I. Markevych, O. McAnirlin, M. J. Nieuwenhuijsen, Mathew P White, S. K. Van Den Eeden   +13 more
semanticscholar   +1 more source

Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics

European Journal of Health Economics, 2022
Policymakers must decide on interventions to control the pandemic. These decisions are driven by weighing the risks and benefits of various non-pharmaceutical intervention alternatives.
A. Mühlbacher, A. Sadler, Y. Jordan
semanticscholar   +1 more source

Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad [PDF]

Vojnosanitetski Pregled, 2016
Background/Aim. Hypertension is one of the leading causes of cardiovascular morbidity and mortality and more than a half of all health insurance expenditures for reimbursed medicines are allocated to antihypertensive drugs in Serbia.
Tomas Ana, Tomić Zdenko, Milijašević Boris, Ban Milica, Horvat Olga, Vukmirović Saša, Sabo Ana   +6 more
doaj   +1 more source

Pharmaceutical procurement among public sector procurers in CARICOM

Revista Panamericana de Salud Pública, 2021
Objective. To examine multiple aspects of the medicines in CARICOM procurement markets, including manufacturer headquarters location, regulatory history, and type (innovator versus generic); the proportion of World Health Organization (WHO) essential ...
Charles Preston, Claire King, Maryam Hinds, Francis Burnett, Rian Marie Extavour   +4 more
doaj   +1 more source

Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines

Applied Health Economics and Health Policy, 2022
Pharmaceutical policies are generally based on the assumption that involved stakeholders make rational decisions. However, behavioral economics has taught us that this is not always the case as people deviate from rational behavior in rather predictable ...
Y. Vandenplas, S. Simoens, F. Turk, A. Vulto, I. Huys   +4 more
semanticscholar   +1 more source

The costs of urinary tract infection therapy with implementation of pharmacoeconomic guidelines at the clinic for infectious diseases of the Clinical center of Vojvodina [PDF]

Vojnosanitetski Pregled, 2012
Beckground/Aim. The Serbian health system does not have strict guidelines for the treatment of bacterial infections. The choice of treatment is empirical which is not necessarily the same compared to the treatment guidelines from countries with a ...
Stefan-Mikić Sandra, Sević Siniša, Doder Radoslava, Cvjetković Dejan, Jovanović Nataša, Ružić Maja   +5 more
doaj   +1 more source

Cost effectiveness comparison of dutasteride and finasteride in patients with benign prostatic hyperplasia - the Markov model based on data from Montenegro [PDF]

Vojnosanitetski Pregled, 2016
Background/Aim. Benign prostatic hyperplasia (BPH) is one of the most common disease among males aging 50 years and more. The rise of the prevalence of BPH is related to aging, and since duration of life time period has the tendency of rising ...
Dabanović Vera, Kostić Marina, Janković Slobodan   +2 more
doaj   +1 more source